Seasonal population dynamics of the primary yellow fever vector Haemagogus leucocelaenus (Dyar & Shannon) (Diptera: Culicidae) is mainly influenced by temperature in the Atlantic Forest, southeast Brazil

BACKGROUND Southeast Brazil has recently experienced a Yellow Fever virus (YFV) outbreak where the mosquito Haemagogus leucocelaenus was a primary vector. Climatic factors influence the abundance of mosquito vectors and arbovirus transmission. OBJECTIVES We aimed at describing the population dynamics of Hg. leucocelaenus in a county touched by the recent YFV outbreak. METHODS Fortnightly egg collections with ovitraps were performed from November 2012 to February 2017 in a forest in Nova Iguaçu, Rio de Janeiro, Brazil. The effects of mean temperature and rainfall on the Hg. leucocelaenus population dynamics were explored. FINDINGS Hg. leucocelaenus eggs were continuously collected throughout the study, with a peak in the warmer months (December-March). The climatic variables had a time-lagged effect and four weeks before sampling was the best predictor for the positivity of ovitraps and total number of eggs collected. The probability of finding > 50% positive ovitraps increased when the mean temperature was above 24ºC. The number of Hg. leucocelaenus eggs expressively increase when the mean temperature and accumulated precipitation surpassed 27ºC and 100 mm, respectively, although the effect of rainfall was less pronounced. MAIN CONCLUSIONS Monitoring population dynamics of Hg. leucocelaenus and climatic factors in YFV risk areas, especially mean temperature, may assist in developing climate-based surveillance procedures to timely strengthening prophylaxis and control.

Development and characterization of a packaging cell line for pseudo-infectious yellow fever virus particle generation

Abstract INTRODUCTION: Pseudo-infectious yellow fever viral particles (YFV-PIVs) have been used to study vaccines and viral packaging. Here, we report the development of a packaging cell line, which expresses the YFV prM/E proteins. METHODS: HEK293 cells were transfected with YFV prM/E and C (84 nt) genes to generate HEK293-YFV-PrM/E-opt. The cells were evaluated for their ability to express the heterologous proteins and to package the replicon repYFV-17D-LucIRES, generating YFV-PIVs. RESULTS: The expression of prM/E proteins was confirmed, and the cell line trans-packaged the replicon for recovery of a reporter for the YFV-PIVs. CONCLUSIONS: HEK293-YFV-prM/E-opt trans-packaging capacity demonstrates its possible biotechnology application.

Metagenomic analysis reveals Hepatitis A virus in suspected yellow fever cases in Brazil

Using a metagenomic approach, we identified hepatitis A virus among cases of acute febrile illnesses that occurred in 2008-2012 in Brazil suspected as yellow fever. These findings reinforce the challenge facing routine clinical diagnosis in complex epidemiological scenarios.

Genome analysis of yellow fever virus of the ongoing outbreak in Brazil reveals polymorphisms

The current yellow fever outbreak in Brazil is the most severe one in the country in recent times. It has rapidly spread to areas where YF virus (YFV) activity has not been observed for more than 70 years and vaccine coverage is almost null. Here, we sequenced the whole YFV genome of two naturally infected howler-monkeys (Alouatta clamitans) obtained from the Municipality of Domingos Martins, state of Espírito Santo, Brazil. These two ongoing-outbreak genome sequences are identical. They clustered in the 1E sub-clade (South America genotype I) along with the Brazilian and Venezuelan strains recently characterised from infections in humans and non-human primates that have been described in the last 20 years. However, we detected eight unique amino acid changes in the viral proteins, including the structural capsid protein (one change), and the components of the viral replicase complex, the NS3 (two changes) and NS5 (five changes) proteins, that could impact the capacity of viral infection in vertebrate and/or invertebrate hosts and spreading of the ongoing outbreak.

Construction and characterization of a recombinant yellow fever virus stably expressing Gaussia luciferase

ABSTRACT Yellow fever is an arthropod-borne viral disease that still poses high public health concerns, despite the availability of an effective vaccine. The development of recombinant viruses is of utmost importance for several types of studies, such as those aimed to dissect virus-host interactions and to search for novel antiviral strategies. Moreover, recombinant viruses expressing reporter genes may greatly facilitate these studies. Here, we report the construction of a recombinant yellow fever virus (YFV) expressing Gaussia luciferase (GLuc) (YFV-GLuc). We show, through RT-PCR, sequencing and measurement of GLuc activity, that stability of the heterologous gene was maintained after six passages. Furthermore, a direct association between GLuc expression and viral replication was observed (r2=0.9967), indicating that measurement of GLuc activity may be used to assess viral replication in different applications. In addition, we evaluated the use of the recombinant virus in an antiviral assay with recombinant human alfa-2b interferon. A 60% inhibition of GLuc expression was observed in cells infected with YFV-GLuc and incubated with IFN alfa-2b. Previously tested on YFV inhibition by plaque assays indicated a similar fold-decrease in viral replication. These results are valuable as they show the stability of YFV-GLuc and one of several possible applications of this construct.

Retention of a recombinant GFP protein expressed by the yellow fever 17D virus in the E/NS1 intergenic region in the endoplasmic reticulum

The flaviviral envelope proteins, E protein and precursor membrane protein, are mainly associated with the endoplasmic reticulum (ER) through two transmembrane (TM) domains that are exposed to the luminal face of this compartment. Their retention is associated with the viral assembly process. ER-retrieval motifs were mapped at the carboxy terminus of these envelope proteins. A recombinant yellow fever (YF) 17D virus expressing the reporter green fluorescent protein (GFP) with the stem-anchor (SA) region of E protein fused to its carboxy terminus was subjected to distinct genetic mutations in the SA sequence to investigate their effect on ER retention. Initially, we introduced progressive deletions of the stem elements (H1, CS and H2). In a second set of mutants, the effect of a length increase for the first TM anchor region was evaluated either by replacing it with the longer TM of human LAMP-1 or by the insertion of the VALLLVA sequence into its carboxy terminus. We did not detect any effect on the GFP localisation in the cell, which remained associated with the ER. Further studies should be undertaken to elucidate the causes of the ER retention of recombinant proteins expressed at the intergenic E/NS1 region of the YF 17D virus polyprotein.

Isolation of yellow fever virus (YFV) from naturally infectied Haemagogus (Conopostegus) leucocelaenus (diptera, cukicudae) in São Paulo State, Brazil, 2009 / Isolamento do vírus da Febre Amarela de mosquitos naturalmente infectados Haemagogus (Conopostegus) leucocelaenus (Diptera, Culicidae), São Paulo, Brasil, 2009

After detecting the death of Howlers monkeys (genus Alouatta) and isolation of yellow fever virus (YFV) in Buri county, São Paulo, Brazil, an entomological research study in the field was started. A YFV strain was isolated from newborn Swiss mice and cultured cells of Aedes albopictus - C6/36, from a pool of six Haemagogus (Conopostegus) leucocelaenus (Hg. leucocelaenus) mosquitoes (Dyar & Shannon) collected at the study site. Virus RNA fragment was amplified by RT-PCR and sequenced. The MCC Tree generated showed that the isolated strain is related to the South American I genotype, in a monophyletic clade containing isolates from recent 2008-2010 epidemics and epizootics in Brazil. Statistical analysis commonly used were calculated to characterize the sample in relation to diversity and dominance and indicated a pattern of dominance of one or a few species. Hg. leucocelaenus was found infected in Rio Grande do Sul State as well. In São Paulo State, this is the first detection of YFV in Hg. leucocelaenus.

Após a detecção de morte de macacos Bugios (gênero Alouatta) e isolamento do vírus da Febre Amarela (YFV) no município de Buri, Estado de São Paulo, Brasil, foi iniciada uma investigação entomológica em campo. Uma cepa de YFV foi isolada em camundongos recém-nascidos e cultura de células de Aedes albopictus - C6/36, a partir de um lote de seis mosquitos Haemagogus (Conopostegus) leucocelaenus (Hg leucocelaenus) Dyar & Shannon coletados no local de estudo. RNA do vírus foi amplificado por RT-PCR e seqüenciado. A topologia gerada indica que a cepa isolada está relacionada ao genótipo South American I, em clado monofilético englobando isolados recentes de epidemias e epizootias entre 2008 e 2009. Análises estatísticas geralmente usadas caracterizaram a amostra em relação à diversidade e dominância, indicando dominância relativa de uma ou poucas espécies. Hg. leucocelaenus foi detectado infectado também no Rio Grande do Sul. No Estado de São Paulo trata-se da primeira detecção do YFV em Hg leucocelaenus.

Estratégias moleculares para utilização do vírus da febre amarela como vetor vacinal / Molecular strategies to use the yellow fever virus as a vaccine vector

A vacina da febre amarela 17D (YFV-17D) é bastante segura e uma dose única confere imunidade potente e duradoura. Por essas e outras características, diferentes tecnologias têm sido propostas para a utilização da cepa 17D como vetor vacinal. Estratégias promissoras para o desenvolvimento de novas vacinas têm se baseado na construção de quimeras YFV-17D com inserção de seqüências heterólogas e produção em larga escala de replicons empacotados em partículas pseudo-infecciosas (PPIs), no entanto, ainda não existe um consenso da melhor estratégia a ser utilizada para esses fins. O presente estudo teve por objetivo avaliar diferentes estratégias de construção para a utilização do YFV-17D como vetor vacinal. Para isso foram construídos duas quimeras do YFV-17D com inserção de um gene repórter YFP (Yellow Fluorescent Protein) na junção E/NS1 e dois replicons subgenômicos do YFV-17D expressando o gene repórter luciferase. Para a produção de PPIs foi desenvolvida a linhagem HEK-YFV-prM/E-opt. O YFV-YFPSSE revelou instabilidade genética com perda do gene YFP e correlação negativa entre expressão de proteínas virais e do gene repórter. O YFV-YFP-DENV1linker mostrou-se estável geneticamente com expressão eficiente de YFP e proteínas virais, e mostrou-se ser o mais adequado para ser utilizado como vetor viral. Os replicons do YFV-17D mostraram-se funcionais e capazes de expressar eficientemente o gene heterólogo. E, embora a linhagem HEK-YFV-prM/E-opt tenha expressado as proteínas estruturais prM e E eficientemente, poucas partículas pseudo-infecciosas foram produzidas. Diante do exposto, as diferentes estratégias de manipulação genética do YFV avaliadas neste trabalho constituem ferramentas viáveis e aplicáveis ao processo de desenvolvimento de vacinas, havendo, porém, necessidade de otimização dessas estratégias para assegurar maiores segurança e eficácia.

The yellow fever vaccine 17D (YFV-17D) is safe and a single dose confers lastingand powerful immunity. For these, different technologies have been proposed for the use of YF-17D strain as a vaccine vector. Promising strategies for the development of new vaccines has been based on chimeric YFV-17D with insertion of heterologous genes and subgenomic replicons packaged into pseudo-infectious particles (PIPs).However, there is still no consensus in the best strategy to be used for suchpurposes. This study aimed to evaluate different strategies for building for the use of YFV-17D as a vector vaccine. For that were constructed two chimeric YFV-17D with insertion of a reporter gene YFP (yellow fluorescent protein) at E/NS1 junction and two subgenomic replicons of YFV-17D expressing the luciferase reporter gene. For the production of PIPs a recombinant cell line were developed (HEK-YFV-prM/E-opt). The YFV-YFP-SSE showed genetic instability with loss of the YFP gene and negative correlation between expression of viral proteins and reporter gene. The YFV-YFPDENV1linker proved to be genetically stable with efficient expression of YFP and viral proteins, and proved to be the most suitable for use as a viral vector. The replicons ofYFV-17D were shown to be functional and able to efficiently express heterologous gene. And although the cell line HEK-YFV-prM/E-opt has expressed efficiently structural viral proteins prM and E, a few of pseudoinfectious particles were produced. In this light, the different strategies of genetic manipulation of YFV measured in this study are feasible and applicable tools to the process of vaccine development, however, the optimization of these strategies is important to ensure greater safety and efficacy.

Attenuation and immunogenicity of recombinant yellow fever 17D-dengue type 2 virus for rhesus monkeys

A chimeric yellow fever (YF)-dengue serotype 2 (dengue 2) virus was constructed by replacing the premembrane and envelope genes of the YF 17D virus with those from dengue 2 virus strains of Southeast Asian genotype. The virus grew to high titers in Vero cells and, after passage 2, was used for immunogenicity and attenuation studies in rhesus monkeys. Subcutaneous immunization of naive rhesus monkeys with the 17D-D2 chimeric virus induced a neutralizing antibody response associated with the protection of 6 of 7 monkeys against viremia by wild-type dengue 2 virus. Neutralizing antibody titers to dengue 2 were significantly lower in YF-immune animals than in YF-naive monkeys and protection against challenge with wild-type dengue 2 virus was observed in only 2 of 11 YF-immune monkeys. An anamnestic response to dengue 2, indicated by a sharp increase of neutralizing antibody titers, was observed in the majority of the monkeys after challenge with wild-type virus. Virus attenuation was demonstrated using the standard monkey neurovirulence test. The 17D-D2 chimera caused significantly fewer histological lesions than the YF 17DD virus. The attenuated phenotype could also be inferred from the limited viremias compared to the YF 17DD vaccine. Overall, these results provide further support for the use of chimeric viruses for the development of a new live tetravalent dengue vaccine.

Uso do vírus da febre amarela vacinal 17D como vetor de expressão para antígenos do vírus dengue / Use of yellow fever vaccine virus 17D as a vector for the expression of dengue virus antigens

O vírus da febre amarela 17D (FA17D) tem várias características que são desejáveis para o desenvolvimento de novas vacinas vivas e atenuadas. Dentre as diversas abordagens possíveis, vírus quiméricos febre amarela 17D (FA17D) - dengue tipo 2 (DEN-2) foram construídos através da substituição dos genes da proteína precursora da proteína de membrana (prM) e da proteína de envelope (E) do vírus FA17D pelos mesmos genes do vírus DEN-2 genótipo do sudeste asiático. Vírus quiméricos viáveis foram recuperados quando o gene do capsídeo (C) de FA17D e o gene prM de DEN-2 foram fusionados no sítio de clivagem da signalase celular, porém não foi possível a recuperação de vírus quiméricos contendo genes de prM/E de DEN-2, a partir de construções fusionadas no sítio de clivagem da protease viral. Diferente do vírus parental FA, que replica em todas as linhagens celulares testadas, e similar ao vírus parental DEN-2, os vírus recombinantes não replicam em células CEF e MRC5... A análise dos ensaios de neurovirulência em camundongo, feitos por inoculação intracerebral, demonstra que a quimera FA17D/DEN-2 é mais atenuada nesse sistema que o vírus FA17DD.A imunização de camundongos com esta quimera induz uma resposta de anticorpos neutralizantes associadas à proteção parcial contra uma dose letal de vírus DEN-2 Nova Guinea C (NGC) neurovirulento para camundongo. Esses resultados dão suporte para o uso futuro de vírus quiméricos como uma metodologia para o desenvolvimento de novas vacinas vivas de flavivírus... Três das seis construções testadas deram origem a vírus recombinantes que apresentaram perfil de crescimento in vitrosemelhante ao vírus FA17D, mas diferiram no perfil de neurovirulência para camundongos. Inserções na alça fg, em geral, levaram a uma redução desta neurovirulência. O presente estudo de expressão de epítopos da proteína NS3 relacionado com a resposta imune celular, embora inicial, sugere que esta proteína contém epítopos envolvidos na exacerbação da resposta imune, fato este que poderia se constituir numa das bases imunológicas para as formas mais graves da doença. Este sistema deve ser mais explorado neste sentido, com a expressão de novos epítopos e o uso de outras metodologias para a caracterização da resposta imune celular neste modelo de expressão de epítopos.

The yellow fever 17D vaccine virus: molecular basis of viral attennuation and it use as an expression vector

The yellow fever (YF) virus is the prototype flavivirus. The use of molecular techniques has unraveled the basic mechanisms of viral genome structure and expression. Recent trends in flavivirus research include the use of infectious clone technology with which it is possible to recover virus from cloned cDNA. Using this technique, mutations can be introduced at any point of the viral genome and their resulting effect on virus phenotype can be assessed. This approach has opened new possibilities to study several biological viral features with special emphasis on the issue of virulence/attenuation of the YF virus. The feasibility of using YF virus 17D vaccine strain, for which infectious cDNA is available, as a vector for the expression of heterologous antigens is reviewed.

Molecular analysis of yellow fever virus 17DD vaccine strain

The Oswaldo Cruz Foundation produces most of the yellow fever (YF) vaccine prepared world wide. As part of a broader approach to determine the genetic variability in YF l7D seeds and vaccines and its relevance to viral attenuation the 17DD virus was purifed directly from chick embryo homogenates which is the source of virus used for vaccination of millions of people in Brazil and other countries for half a century. Neutralization and hemagglutination tests showed that the purified virus is similar to the original stock. Furthermore, radioimmune precipitation of 35S-methionine-labeled viral proteins using mouse hyperimmune ascitic fluid revealed identical patterns for the purified 17DD virus and the YF l7D-204 strain except for the 17DD E protein which migrated slower on SDS-PAGE. This difference is likely to be due to N-linked glycosylation. Finally, comparison by northern blot nybridization of virion RNAs of purified 17DD with two other strains of YF virus only fenome-sized molecules for all three viruses. These observations suggest that vaccine phenotype is primarily associated with the accumulation of mutations